Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method to induce cytotoxic T Lymphocytes specific for a broad array of HIV-1 isolates using hybrid synthetic peptides

Method to induce cytotoxic T Lymphocytes specific for a broad array of HIV-1 isolates using hybrid synthetic peptides

US Patent 5820865 · Granted Oct 13, 1998

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

3-o-sulfo-galactosylceramide analogs as activators of type II NKT cells and uses2025
Purification and labeling of extracellular vesicles using a mixed mode resin com2024
Molecular nanotags2022
Method and composition for optical clearing of tissues2022
Mixed gas supply device2022
Compositions and methods for the treatment of HER2-expressing solid tumors2022
Optical configuration methods for spectral scatter flow cytometry2020
Evaluation device2020
Multi-epitope TARP peptide vaccine and uses thereof2019
Evaluation apparatus and evaluation method2018
Beta-mannosylceramide and stimulation of NKT cell anti-tumor immunity2016
Vaccines and methods for prevention and treatment of drug-resistant HIV-1 and he2016